MENLO PARK, Calif., Sept. 2, 2015 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX) a Silicon Valley-based specialty pharmaceutical company today announced that Jim Pekarsky, chief executive officer and co-founder of BioPharmX, will present at the Rodman & Renshaw 17th Annual Global Investment Conference taking place, September 8-10, 2015 at The St. Regis Hotel, New York.

BioPharmX (BPMX)

Mr. Pekarsky is scheduled to present on September 10 from 2:10 to 2:35 PM EDT in Astor Suite A (2nd floor).

A live webcast of the presentation will be available at http://wsw.com/webcast/rrshq25/bpmx and will be archived for 365 days following the presentation.

About BioPharmX Corporation
BioPharmX Corporation (NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical company, which seeks to provide products through proprietary platform technologies for prescription, over-the-counter ("OTC"), and supplement applications in the health and wellness markets, including women's health and dermatology. To learn more about BioPharmX, visit www.BioPharmX.com.

BioPharmX is a registered trademark of BioPharmX, Inc.  All other brand names are trademarks or registered trademarks of their respective holders.

Logo - http://photos.prnewswire.com/prnh/20150711/235327LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biopharmx-corporation-to-present-at-rodman--renshaw-17th-annual-global-investment-conference-300136451.html

SOURCE BioPharmX Corporation

Copyright 2015 PR Newswire

Grafico Azioni BioPharmX (AMEX:BPMX)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di BioPharmX
Grafico Azioni BioPharmX (AMEX:BPMX)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di BioPharmX